Skip to content

Nuvation Bio NUVB Lessee Operating Lease Liability Undiscounted Excess Amount

Lessee Operating Lease Liability Undiscounted Excess Amount at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.25B+150%

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's lessee operating lease liability undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's lessee operating lease liability undiscounted excess amount?
Nuvation Bio (NUVB) reported lessee operating lease liability undiscounted excess amount of $557K in Q4 2025.
How has Nuvation Bio's lessee operating lease liability undiscounted excess amount changed year-over-year?
Nuvation Bio's lessee operating lease liability undiscounted excess amount increased by 289.5% year-over-year, from $143K to $557K.
What is the long-term trend for Nuvation Bio's lessee operating lease liability undiscounted excess amount?
Over 4 years (2021 to 2025), Nuvation Bio's lessee operating lease liability undiscounted excess amount has grown at a 6.4% compound annual growth rate (CAGR), from $434K to $557K.